Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy; a Placebo-controlled Trial

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

2,514

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2031

Conditions

Myocardial Infarction (MI)Cardiovascular EventsPost Polypectomy Bleeding in Antiplatelet Patients

Interventions

DRUG

Aspirin 80mg

8-day (-5, +3) supply of aspirin 80mg before and after colonoscopy

DRUG

Placebo Oral Tablet

8-day (-5, +3) supply of placebo before and after colonoscopy

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER